Viatris Inc. to Participate in Barclays Global Healthcare Conference
Viatris Inc. (NASDAQ: VTRS) will participate in a virtual fireside chat at the Barclays Global Healthcare Conference on March 10, 2021, at 3:00 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Viatris Inc. (NASDAQ: VTRS) will participate in a virtual fireside chat at the Barclays Global Healthcare Conference on March 10, 2021, at 3:00 p.m. ET. Key executives including CEO Michael Goettler, President Rajiv Malik, and CFO Sanjeev Narula will address questions regarding the company. A live webcast can be accessed at investor.viatris.com, with an archived version available afterward. Viatris, formed in November 2020 from Mylan and Pfizer's Upjohn business, aims to enhance global healthcare access.
Details
News Market Reaction – VTRS
The recorded move for VTRS in the trading session of this news was -2.09%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PITTSBURGH, March 4, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the Barclays Global Healthcare Conference on Wednesday March 10, 2021. CEO Michael Goettler, President Rajiv Malik and Chief Financial Officer Sanjeev Narula will answer questions about the company at 3:00 p.m. ET.
Interested parties can access a live webcast of the event at investor.viatris.com. An archived version also will be available following the live event and can be accessed at the same location for a limited time.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020 through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
View original content to download multimedia:http://www.prnewswire.com/news-releases/viatris-inc-to-participate-in-barclays-global-healthcare-conference-301240835.html
SOURCE Viatris Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.